Gilead's $21 Billion Deal Splurge May End in Regret
Gilead
Pharmaceuticals Inc. has faced the same problem for years: The drugmaker has
a strong core business in its world-leading HIV franchise, but it ...
|
View article...
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.
Gilead
Pharmaceuticals Inc. has faced the same problem for years: The drugmaker has
a strong core business in its world-leading HIV franchise, but it ...
|